- Bob Roehr
- 1Washington, DC
A large cancer screening programme in the United States has changed its screening practice and treatment strategy after learning that the effectiveness of chemoradiation for oropharyngeal cancer differs depending on whether the tumour is caused by human papillomavirus (HPV) infection. The discovery may also explain the stark difference in response to treatment seen between black and white people.
The findings led the University of Maryland Cancer Center study site, in Baltimore, to immediately change its screening and treatment practices, even before publication (Cancer Prevention Research 2009 July 29, doi:10.1158/1940-6207.CAPR-09-0149).
The study retrospectively analysed biopsy specimens of tumours from a large clinical trial for the presence of HPV. It found that survival was nearly five …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Ventilator associated pneumonia
Published 30 May 2012
Re: Restless legs syndrome
Published 30 May 2012
Author's reply
Published 30 May 2012
Re: Full access to trial data holds many benefits and a few pitfalls, conference hears
Published 30 May 2012
Restless Legs Syndrome: Fact or Fiction
Published 30 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27